Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23andMe Holding Co. - Common Stock (NQ: ME )

1.815 +0.045 (+2.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2023
Data from the Phase 1 portion of the 23ME-00610 Phase 1/2a study, including safety, pharmacokinetics, and the recommended Phase 2a dose to be presented 
From 23andMe Holding Co.
Via GlobeNewswire
AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023
They've been using machine learning for years, and now they might do even more. 
Via The Motley Fool
New 23andMe Surveys Find Most People and Doctors Agree that Genetic Testing Offers Promise for More Personalized Healthcare
From 23andMe Holding Co.
Via GlobeNewswire
2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise
There's nothing better than getting a bargain that'll pay off for years. 
Via The Motley Fool
This Genetics Stock Could Have Massive Long-Term Potential
This healthcare company isn't without risk but is doing a good job executing on its vision. 
Via The Motley Fool
A Preview Of 23andMe Holding's Earnings
Via Benzinga
2 High-Growth Stocks That Could Double Your Money in 5 Years or Less
Both are likely to double quite soon, and they aren't even that risky. 
Via The Motley Fool
23andMe Announces First Patient Dosed for the Phase 2a Portion of its Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 in Patients with Advanced Solid Malignancies
The expansion portion of the study will evaluate the anti-cancer activity of 23ME-00610 in specific tumor indications, and will further characterize the safety, tolerability, pharmacokinetic and... 
From 23andMe Holding Co.
Via GlobeNewswire
23andMe to Present at Upcoming Investor Conferences
From 23andMe Holding Co.
Via GlobeNewswire
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
23andMe Reports FY2023 Third Quarter Financial Results
From 23andMe Holding Co.
Via GlobeNewswire
7 Former SPACs I Still Own (And What I Think Now)
Remember the SPAC boom? Here are seven products of that time that are still in my portfolio. 
Via The Motley Fool
23andMe to Report FY2023 Third Quarter Financial Results
From 23andMe Holding Co.
Via GlobeNewswire
3 Penny Stocks That Could Make You Filthy Rich
These low-priced equities could deliver enormous returns for risk-tolerant shareholders. 
Via The Motley Fool
My 4 Worst-Performing Stocks and What I Think Now
These stocks are all down 70% or more from what I paid. 
Via The Motley Fool
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
25 Meme Stocks to Sell Before They Die
Wondering what the best meme stocks to sell for 2023 are? Here are the top picks that investors should offload and avoid. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
The Worst Investment Decision I Made in 2022
The stock market has had a terrible year, and here are some moves we wish we could do over. 
Via The Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share. 
Via Benzinga
23andMe Survey Shows Majority of People Less Stressed About Their Health During This Holiday Season
From 23andMe Holding Co.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
Via Benzinga
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes. 
Via TheNewswire.com
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes.  
Via Benzinga
23andMe Reports FY2023 Second Quarter Financial Results
From 23andMe Holding Co.
Via GlobeNewswire
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
The presentation outlines plans for the expansion phase of the study (part B), including the specific tumor indications where 23ME-00610 will be tested for anticancer activity 
From 23andMe Holding Co.
Via GlobeNewswire
A Preview Of 23andMe Holding's Earnings
23andMe Holding (NASDAQ:ME) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that 23andMe Holding... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS